Ingevity CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Ingevity Corporation's Q2 2026 results show a net sales decrease driven by divestitures, with segment performance varying across its business units.
NYSE
Ingevity Corporation announced its first quarter 2026 financial results, highlighting a net sales increase driven by pricing and favorable foreign exchange, alongside progress in strategic divestitures.
NYSE
Ingevity Corporation reported a significant improvement in net income for Q3 2025, driven by reduced losses from discontinued operations, despite flat net sales and a downward revision to its full-year outlook.
NYSE
Ingevity Corporation reported a reduced net loss in Q2 2025, driven by strategic repositioning efforts and improved cash flow, despite a significant goodwill impairment in its Advanced Polymer Technologies segment.
NYSE
Ingevity Corporation's Q1 2025 results show a mixed performance with decreased net sales offset by improved profitability in certain segments, leading to an adjusted full-year outlook reflecting industry forecasts.
NYSE
Ingevity Corporation's Q3 2024 results reflect a net loss, impacted by restructuring charges and lower sales volumes, particularly in the Performance Chemicals segment.
NYSE
Ingevity Corporation reported a significant net loss for the second quarter of 2024, primarily due to a goodwill impairment charge and restructuring costs.
NYSE
Ingevity Corporation's first quarter 2024 results reflect a net loss due to restructuring charges and decreased sales, despite some gains in Performance Materials.